Understanding and Assessing Heart Risks
At a Glance
In Carvajal syndrome, heart risk cannot be judged by pumping strength alone. Doctors combine LVEF, Holter rhythm findings, cardiac MRI scarring, prior myocarditis-like episodes, and DSP-specific risk tools to guide monitoring and possible ICD decisions.
Because Carvajal syndrome can lead to serious heart rhythm issues and heart failure, doctors use a process called risk stratification. This means they look at several different pieces of information to determine the likelihood of a major event and decide if treatments like an ICD (implantable cardioverter-defibrillator) are considered [1][2].
Why Standard Risk Models May Not Fit
For many years, doctors used risk models designed for a similar condition called ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy). However, those models were built around the right side of the heart. Since Carvajal syndrome primarily affects the left ventricle (the heart’s main pumping chamber), standard ARVC calculators often may misestimate the risk for these children [3][4]. In one study, nearly 1 in 4 patients who experienced a dangerous heart rhythm did not meet the traditional criteria used for ARVC [4][5].
Key Variables in Risk Assessment
To get a more accurate picture, your child’s team will track several specific “prognostic variables”:
1. Ejection Fraction (LVEF)
The Left Ventricular Ejection Fraction (LVEF) is a measurement of how much blood the left ventricle pumps out with each contraction. A normal LVEF is usually above 50–55%. While a lower LVEF (below 50%) is a known risk factor for both heart failure and dangerous rhythms, it is important to know that serious arrhythmias can sometimes happen even when the pumping function still looks normal [6][3].
2. PVC Burden and Heart Rhythms
A Holter monitor (a 24-hour heart recorder) measures PVCs (premature ventricular contractions), which are “extra” heartbeats. Doctors look at the total number of these beats in a day, as well as episodes of NSVT (non-sustained ventricular tachycardia), which are short bursts of rapid heartbeats [1][6]. A higher burden of these irregular beats is a key indicator that the heart’s electrical system is under stress [7].
3. Late Gadolinium Enhancement (LGE)
During a Cardiac MRI, a contrast agent is used to look for LGE, which indicates imaging patterns consistent with tissue injury, inflammation, or scarring (fibrosis) [3].
- The Hidden Risk: LGE is a critical marker because it can identify damage to the heart muscle that an ultrasound (echocardiogram) cannot see. In some children, LGE is visible even when the heart’s pumping function is completely normal [3][8].
- The Pattern: In Carvajal syndrome, scarring often forms a “ring-like” pattern around the heart muscle. This tissue can act like an electrical “short circuit,” potentially triggering dangerous heart rhythms, though it is not an obligatory finding [9][10].
The Importance of ‘Hot Phases’
If your child has ever had an episode of chest pain or a rise in heart enzymes (troponin) that looked like a heart infection (myocarditis), this is often called a “hot phase” [11]. Any chest pain requires urgent evaluation to rule out infectious myocarditis or other causes. In Carvajal syndrome, these are not just one-time infections; they are myocarditis-like episodes associated with active heart muscle injury related to the genetic mutation. Research shows that experiencing these episodes is associated with a future risk of both heart failure and serious heart rhythm issues [6][4].
Specialized DSP Risk Models
Recently, researchers have developed risk models specifically for patients with DSP mutations (like those with Carvajal syndrome). These models combine several factors—including your child’s sex, their history of rapid heartbeats, their 24-hour PVC count, and their LVEF—to provide a more personalized risk estimate [1]. These tools help your electrophysiologist assess the risk for your child’s specific situation, but they are research-derived tools and decisions must be highly individualized [1][7].
Because risk can change over time, these variables are re-evaluated regularly. This ongoing assessment allows your medical team to stay one step ahead, ensuring that your child receives the right protection at the right time [9][6].
Common questions in this guide
How is heart risk assessed in a child with Carvajal syndrome?
Can a dangerous heart rhythm occur when a child's ejection fraction is normal?
Why might an ARVC risk calculator be less reliable for Carvajal syndrome?
What does late gadolinium enhancement on a cardiac MRI mean?
What is a myocarditis-like hot phase, and why does it matter?
When might an ICD be discussed for a child with Carvajal syndrome?
One line in your results can change your plan.
Holter PVC counts and cardiac MRI scarring are among the results that can help decide whether an ICD is considered. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Carvajal syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.
Carrick RT, Gasperetti A, Protonotarios A, et al.
European heart journal 2024; (45(32)):2968-2979 doi:10.1093/eurheartj/ehae409.
PMID: 39011630 - 2
A case of Carvajal syndrome presenting with dilated cardiomyopathy.
Arıcı S, Akalın F, Geckinli BB
Cardiology in the young 2024; (34(5)):1131-1133 doi:10.1017/S1047951124000222.
PMID: 38433550 - 3
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
Smith ED, Lakdawala NK, Papoutsidakis N, et al.
Circulation 2020; (141(23)):1872-1884 doi:10.1161/CIRCULATIONAHA.119.044934.
PMID: 32372669 - 4
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy.
Wang W, Murray B, Tichnell C, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(2)):268-277 doi:10.1093/europace/euab183.
PMID: 34352074 - 5
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy?
Kukavica D, Trancuccio A, Arnò C, et al.
Minerva cardiology and angiology 2022; (70(2)):217-237 doi:10.23736/S2724-5683.21.05804-X.
PMID: 34338490 - 6
Clinical features and outcomes in carriers of pathogenic desmoplakin variants.
Gasperetti A, Carrick RT, Protonotarios A, et al.
European heart journal 2025; (46(4)):362-376 doi:10.1093/eurheartj/ehae571.
PMID: 39288222 - 7
Genotype and cardiac outcome in patients with cardiocutaneous syndrome (Naxos disease variant: Carvajal syndrome).
Binfadel M, Aleem MU, Alhabdan M, et al.
Orphanet journal of rare diseases 2025; (20(1)):137 doi:10.1186/s13023-025-03612-8.
PMID: 40108711 - 8
Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies.
Piriou N, Marteau L, Kyndt F, et al.
ESC heart failure 2020; (7(4)):1520-1533 doi:10.1002/ehf2.12686.
PMID: 32356610 - 9
Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.
Smith E, Gasperetti A, Carrick RT, et al.
medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.06.16.25329734.
PMID: 40666337 - 10
Three-dimensional Mapping of Fibrosis Distribution in Desmoplakin Cardiomyopathy from Cardiac MRI.
Jilberto J, McManus B, Moghrabi A, et al.
Radiology. Cardiothoracic imaging 2026; (8(4)):e260010 doi:10.1148/ryct.260010.
PMID: 42461100 - 11
Arrhythmogenic cardiomyopathy in children, on the link between injurious mutations and inflammation: Two case reports and review of the literature.
Nikitina E, Kofeynikova O, Zlotina A, et al.
World journal of clinical pediatrics 2025; (14(4)):108329 doi:10.5409/wjcp.v14.i4.108329.
PMID: 41255689
This page explains heart-risk assessment in children with Carvajal syndrome for informational purposes only and does not constitute medical advice. Your child's cardiologist and electrophysiologist should interpret test results and discuss monitoring or ICD decisions.